An investigation on behalf of investors in BIOLASE Inc shares over potential wrongdoing at BIOLASE Inc was announced and NASDAQ:BIOL stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 12/02/2016 -- An investigation on behalf of investors in shares of BIOLASE Inc (NASDAQ:BIOL) was announced over potential breaches of fiduciary duties by certain officers and directors.
Investors who purchased shares of BIOLASE Inc (NASDAQ:BIOL) and currently hold any of those NASDAQ:BIOL shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm concerns whether certain BIOLASE officers and directors breached their fiduciary duties.
BIOLASE Inc reported that its annual Total Revenue rose from $47.66 million in 2014 to $48.48 million in 2015 and that its Net Loss increased from $18.93 million in 2014 to $20.28 million in 2015.
Shares of BIOLASE Inc (NASDAQ:BIOL) declined from $2.97 per share in late 2014 to as low as $0.62 per share in late 2015.
On December 1, 2016, NASDAQ:BIOL shares closed at $1.65 per share.
Those who purchased shares of BIOLASE Inc have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com